Sep 13, 2021 / 01:30PM GMT
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive Director
Thanks for joining us again for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Very pleased to have Organon with us for the next session.
I need to read a quick disclosure statement before we get started. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures are seen on Morgan Stanley public website at morganstanley.com/researchdisclosures.
And very pleased to have from Organon, Kevin Ali, the CEO; and Matt Walsh, the CFO.
Questions and Answers:
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive DirectorKevin, I thought maybe just to start us off, since obviously, people are familiar with the company because of the spin from Merck, but may not be as familiar with the focus of the company and the key products. Maybe we could just take a minute or 2 to walk through what the vision is for the company and how you're thinking about the